New York, NYNCT05425004Now EnrollingIRB Ready

Meningioma Clinical Trial in New York, NY

Access cutting-edge meningioma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Baptist Health South Florida

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions...

Expert Care in New York

Access meningioma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related meningioma treatment provided free

Apply for This New York Location

Check if you qualify for this meningioma clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Meningioma Study in New York

A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

Sponsor: Baptist Health South Florida

Who Can Participate

Inclusion Criteria

Histologic (preferred) or radiologic diagnosis of meningioma. All World Health Organization (WHO) grades (I, II and III) are allowed. 2. All patients must have developed recurrent disease or progressive disease after receiving standard therapy (e.g., radiation or surgery) \> 6 months ago or have been deemed ineligible to receive these therapies. 3. Karnofsky Performance Status ≥ 50. 4. Adequate hematologic function: 1. Absolute Neutrophil Count ≥ 1.5 x 10\^9 / L without granulocyte colony-stimulating factor support. 2. Platelet Count ≥ 100 x 10\^9 / L without transfusion. 3. Hemoglobin ≥ 9 g/dL without transfusion within 7 days prior to screening assessment. 5. Adequate renal function: ≥ 30 ml/min according to the Cockcroft-Gault formula. 6. Adequate hepatic function including: 1. Total bilirubin ≤ 1.5 x upper limit of normal (ULN). 2. Aspartate transaminase (AST) ≤ 3 x ULN without liver metastasis. 3. Alanine transaminase (ALT) ≤ 3 x ULN with

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT05425004) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Meningioma Treatment Options in New York, NY

If you're searching for meningioma treatment options in New York, NY, this clinical trial (NCT05425004) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced meningioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all meningioma clinical trials near you to find additional studies recruiting in your area.

More Myalgic Encephalomyelitis Trials in New York, NY

See all myalgic encephalomyelitis clinical trials recruiting in New York — not just this study.

Browse Myalgic Encephalomyelitis Trials in New York →

Browse More Trials by Condition

Myalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY